triple negative breast cancer treatment 2023

Release time ：Dec-18,2024

In 2023, the treatment landscape for triple-negative breast cancer typically encompasses a range of approaches including surgery, radiotherapy, and chemotherapy.

Surgery stands as a prevalent method for managing triple-negative breast cancer, encompassing both breast-conserving procedures and total mastectomies. Depending on the individual patient's circumstances post-surgery, radiotherapy might be indicated to mitigate the risk of recurrence. Chemotherapy also holds a significant position in the treatment paradigm, often administered pre- or post-operatively to shrink tumor size or to eradicate any remaining cancer cells. Furthermore, innovative therapies such as immunotherapy and targeted therapy are in ongoing research and development, offering novel treatment options for certain patients. The choice and application of these therapeutic strategies must be tailored to the patient's specific medical condition, physical health, and response to treatment, with a personalized treatment plan crafted by specialized physicians.

For individuals diagnosed with triple-negative breast cancer, it is advised to seek prompt medical attention and to undergo standardized treatment under a physician's supervision. Additionally, maintaining healthy lifestyle habits, including a balanced diet and regular physical activity, can contribute to enhanced therapeutic outcomes and overall quality of life. Always remember that medication should be used only under a doctor's guidance and self-medication should be avoided.